Are you Dr. Middleton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 619-543-3405
Summary
- Dr. Michael Middleton, MD is a radiologist in San Diego, California. He is currently licensed to practice medicine in California. He is affiliated with UC San Diego Medical Center - Hillcrest.
Education & Training
University of California (San Diego) Medical CenterResidency, Radiology-Diagnostic, 1986 - 1990
Scripps Mercy HospitalInternship, Transitional Year, 1985 - 1986
University of California, Irvine, School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1987 - 2025
Publications & Presentations
PubMed
- Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.Kang Wang, Guilherme Moura Cunha, Kyle Hasenstab, Walter C Henderson, Michael S Middleton
AJR. American Journal of Roentgenology. 2023-11-01 - 17 citationsRepeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.Kathryn J Fowler, Sudhakar K Venkatesh, Nancy Obuchowski, Michael S Middleton, Jun Chen
Radiology. 2023-10-01 - 1 citationsAssociation of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children.Ghattas J Malki, Nidhi P Goyal, Patricia Ugalde-Nicalo, Lauren F Chun, Jasen Zhang
Metabolic Syndrome and Related Disorders. 2023-05-01
Press Mentions
Median Technologies Organisera Une Table Ronde Médicale Et Scientifique Ayant Pour Thème L’utilisation De Sa Plateforme Innovante D’imagerie Phénomique iBiopsy® Pour La Stéatohépatite Non Alcoolique (Nonalcoholic Steatohepatitis – NASH)September 5th, 2017- Median Technologies to Lead a Scientific and Medical Round Table to Discuss the Application of Its Groundbreaking Imaging Phenomics Platform Ibiopsy® for Nonalcoholic Steatohepatitis (NASH)September 5th, 2017
